Data / Form D filings / BiomX Inc.
BiomX Inc.: Form D filings
BiomX Inc., a pharmaceuticals company in Ness Ziona, Israel, filed 5 Form D notices with the SEC between 2021 and 2026. The latest, on January 20, 2026, reports $3.3 million sold of a $3.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22 EINSTEIN STREET, FLOOR 4, Ness Ziona, Israel, 74140
- Phone
- +972 723942377
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1739174
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | New notice | $3,300,000 | $3,300,000 | 1 | Jan 13, 2026 | sec.gov | |
| Apr 1, 2024 | New notice | $61,547,439 | $61,547,439 | 34 | Mar 15, 2024 | sec.gov | |
| Mar 3, 2023 | New notice | $7,484,390 | $1,461,324 | $6,023,066 | 10 | Feb 27, 2023 | sec.gov |
| Jan 4, 2022 | New notice | $4,998,293 | $3,000,000 | $1,998,293 | 1 | Dec 21, 2021 | sec.gov |
| Oct 25, 2021 | New notice | $3,000,000 | $3,000,000 | 1 | Oct 14, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Solomon | Executive Officer, Director | Chief Executive Officer |
| Marina Wolfson | Executive Officer | Chief Financial Officer |
| Merav Bassan | Executive Officer | Chief Development Officer |
| Susan Blum | Director | |
| Jesse Goodman | Director | |
| Russell Greig | Director | |
| Jonathan Leff | Director | |
| Gregory Merril | Director | |
| Alan Moses | Director | |
| Eddie Williams | Director |
Every Form D from the week of Jan 19, 2026 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BiomX Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.